Nexavar (Sorafanib) with Chemo in Front Line Advanced NSCLC Fails to Improve Survival
Article
I'll get back to the storyline of our growing understanding of the differences of individuals based on pharmacogenomics very soon. But I wanted to give people some breaking news that just came out.